Benzylamine derivative

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S017000, C546S018000, C546S225000, C546S229000, C514S330000, C514S331000

Reexamination Certificate

active

10566252

ABSTRACT:
The invention provides a compound which exhibits satisfactory peroral absorbability and excellent antagonistic activity against NK-1 receptor or NK-2 receptor. The compound is a benzylamine derivative represented by formula (1) or a salt thereof

REFERENCES:
patent: 5789422 (1998-08-01), Reichard et al.
patent: 5869496 (1999-02-01), Hale et al.
patent: 8-505880 (1996-06-01), None
patent: 8-511522 (1996-12-01), None
patent: 11-043490 (1999-02-01), None
patent: 2001-507673 (2001-06-01), None
patent: 2002-520316 (2002-07-01), None
patent: 94/17045 (1994-08-01), None
patent: 94/26735 (1994-11-01), None
patent: 94/29309 (1994-12-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Benzylamine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzylamine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzylamine derivative will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3856346

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.